Cipla’s arm completes acquisition of stake in Wellthy Therapeutics
Cipla’s wholly owned subsidiary — Goldencross Pharma has completed the closing of Wellthy Therapeutics, transaction representing an acquisition of 11.71% stake in Wellthy on fully diluted basis on March 08, 2019. Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio … Read more
